455,188 HIV medication bottles arrive in the Philippines

The Department of Health said 455,188 anti-retroviral bottles for treating people living with HIV have arrived in the Philippines. The medicines are scheduled for distribution next week.

The DOH said the Lamivudine+Tenofovir+Dolutegravir or LTD passed inspection and is safe, effective, high-quality and registered with the Food and Drug Administration.

It is expected that the first tranche of HIV ARVs will be completed in the coming weeks and will also undergo inspection. The second and third tranches are expected to arrive in August and September this year.

Supplier Phil Pharmawealth will bring in 1.2 million bottles of LTD in total. The first batch of 600,000 bottles was set for delivery last May but delayed after the supplier cited the Middle East crisis.

Articoli correlati

Chilean Air Force plane taking off with humanitarian aid to Venezuela
Immagine generata dall'IA

Chile sends third humanitarian flight to Venezuela with vaccines and medicines

Riportato dall'IA Immagine generata dall'IA

A Chilean Air Force plane took off Friday night bound for Caracas carrying 35,000 vaccines, medicines, food and aid kits.

UNAIDS has welcomed South Africa’s rollout of Lenacapavir as a landmark step in HIV prevention. The injectable is now available at 360 public health facilities across six provinces. The drug has also been added to the national essential medicines list.

Riportato dall'IA

South Africa has started rolling out the twice-yearly HIV prevention injection lenacapavir, though success depends on managing interactions with common tuberculosis medicines.

The Ethiopian Pharmaceutical Supply Services has proposed a multi-vendor procurement system to tackle ongoing medicine sourcing challenges. The system has yet to be implemented.

Riportato dall'IA

A shipment with more than 32,000 doses against influenza, hepatitis A and tetanus arrived in the Coquimbo region on Wednesday. Health authorities began administering them to groups at risk due to the rains, while influenza vaccination expanded nationwide to the entire population starting Thursday.

Pharco Pharmaceuticals prevede di investire circa 1,5 miliardi di EGP il prossimo anno, in aumento rispetto agli 1,15 miliardi di EGP del 2025, per espandere la capacità produttiva e rafforzare la propria presenza sui mercati nazionali ed esteri, ha dichiarato la presidente Sherine Helmy. L'azienda sta dando priorità ai miglioramenti nella qualità del prodotto, oltre all'espansione e alla diversificazione delle linee di produzione.

Riportato dall'IA

Il ministro della Salute egiziano, Khaled Abdel Ghaffar, ha sollecitato un rafforzamento della produzione farmaceutica locale per costruire catene di approvvigionamento sanitario resilienti.

 

 

 

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta